IDEAS home Printed from https://ideas.repec.org/a/kap/ejlwec/v35y2013i1p61-85.html
   My bibliography  Save this article

The market of human experimentation

Author

Listed:
  • Roberto Ippoliti

Abstract

How should experiments on humans be regulated and controlled? Is it possible to create an equilibrium between the optimal protection of patients’ rights and all the other interests involved? This paper analyzes the problem from a Law and Economics point of view and tries to develop a theoretical model that would provide a way to achieve that equilibrium, both in terms of effectiveness and efficiency, a model in which the interaction between different parties can lead to a market where information is exchanged for innovation. This paper is based on work that has been done up to now by other sciences, like medicine and bioethics, treating the issue with an alternative approach in order to propose an oversight system able to give an answer to this unsolved problem. This work is mainly aimed at defining the rules of the market in Europe, including its actors and their interactions using both a normative and a positive approach. Both the behavior of rational people and that of bounded ones are analyzed, as well as the strategies that can be applied against the latter by stronger parties. Finally, the public stakeholder’s role in preventing this from happening is analyzed. Copyright Springer Science+Business Media, LLC 2013

Suggested Citation

  • Roberto Ippoliti, 2013. "The market of human experimentation," European Journal of Law and Economics, Springer, vol. 35(1), pages 61-85, February.
  • Handle: RePEc:kap:ejlwec:v:35:y:2013:i:1:p:61-85
    DOI: 10.1007/s10657-010-9190-y
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s10657-010-9190-y
    Download Restriction: Access to full text is restricted to subscribers.

    File URL: https://libkey.io/10.1007/s10657-010-9190-y?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Anup Malani, 2006. "Identifying Placebo Effects with Data from Clinical Trials," Journal of Political Economy, University of Chicago Press, vol. 114(2), pages 236-256, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Greta Falavigna & Roberto Ippoliti & Marinella Bertolotti & Franca Riva & Antonio Maconi, 2017. "Supportare la ricerca e l’innovazione in sanità tramite i modelli organizzativi: il caso dell’Azienda Ospedaliera “SS. Antonio e Biagio e Cesare Arrigo” di Alessandria/Supporting research and innovati," IRCrES Working Paper 201709, Research Institute on Sustainable Economic Growth - Moncalieri (TO) ITALY - former Institute for Economic Research on Firms and Growth - Moncalieri (TO) ITALY.
    2. Roberto Ippoliti, 2012. "Making profits working on patients’ expectations, a behavioral analysis of pharmaceutical clinical research," Journal of Bioeconomics, Springer, vol. 14(3), pages 217-241, October.
    3. Roberto Ippoliti & Greta Falavigna, 2013. "Subjects’ decision-making process: an empirical analysis on patients’ mobility process and the role of pharmaceutical clinical research," International Review of Economics, Springer;Happiness Economics and Interpersonal Relations (HEIRS), vol. 60(3), pages 319-342, September.
    4. Roberto Ippoliti & Greta Falavigna, 2014. "Public Health Institutions, Clinical Research and Protection System of Patients’ Rights: An Impact Evaluation of Public Policy," Public Organization Review, Springer, vol. 14(2), pages 109-125, June.
    5. Ippoliti, Roberto & Falavigna, Greta, 2012. "Efficiency of the medical care industry: Evidence from the Italian regional system," European Journal of Operational Research, Elsevier, vol. 217(3), pages 643-652.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sylvain Chassang & Erik Snowberg & Ben Seymour & Cayley Bowles, 2015. "Accounting for Behavior in Treatment Effects: New Applications for Blind Trials," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-13, June.
    2. Steven D. Levitt & John A. List, 2011. "Was There Really a Hawthorne Effect at the Hawthorne Plant? An Analysis of the Original Illumination Experiments," American Economic Journal: Applied Economics, American Economic Association, vol. 3(1), pages 224-238, January.
    3. van den Berg, Gerard J, 2007. "An Economic Analysis of Exclusion Restrictions for Instrumental Variable Estimation," CEPR Discussion Papers 6157, C.E.P.R. Discussion Papers.
    4. Chad D. Meyerhoefer & Muzhe Yang, 2011. "The Relationship between Food Assistance and Health: A Review of the Literature and Empirical Strategies for Identifying Program Effects," Applied Economic Perspectives and Policy, Agricultural and Applied Economics Association, vol. 33(3), pages 304-344.
    5. Gani Aldashev & Georg Kirchsteiger & Alexander Sebald, 2017. "Assignment Procedure Biases in Randomised Policy Experiments," Economic Journal, Royal Economic Society, vol. 127(602), pages 873-895, June.
    6. Sylvain Chassang & Gerard Padro I Miquel & Erik Snowberg, 2012. "Selective Trials: A Principal-Agent Approach to Randomized Controlled Experiments," American Economic Review, American Economic Association, vol. 102(4), pages 1279-1309, June.
    7. Jens Ludwig & Jeffrey R. Kling & Sendhil Mullainathan, 2011. "Mechanism Experiments and Policy Evaluations," Journal of Economic Perspectives, American Economic Association, vol. 25(3), pages 17-38, Summer.
    8. Jose M. Fernandez, 2013. "An Empirical Model Of Learning Under Ambiguity: The Case Of Clinical Trials," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, vol. 54(2), pages 549-573, May.
    9. Roberto Ippoliti, 2012. "Making profits working on patients’ expectations, a behavioral analysis of pharmaceutical clinical research," Journal of Bioeconomics, Springer, vol. 14(3), pages 217-241, October.
    10. Chemla, Gilles & Hennessy, Christopher A., 2019. "Controls, belief updating, and bias in medical RCTs," Journal of Economic Theory, Elsevier, vol. 184(C).
    11. Tat Y. Chan & Barton H. Hamilton, 2006. "Learning, Private Information, and the Economic Evaluation of Randomized Experiments," Journal of Political Economy, University of Chicago Press, vol. 114(6), pages 997-1040, December.
    12. Chemla, Gilles & Hennessy, Christopher, 2016. "Bayesian Expectancy Invalidates Double-Blind Randomized Controlled Medical Trials," CEPR Discussion Papers 11360, C.E.P.R. Discussion Papers.
    13. Armando Franco & Dana P. Goldman & Adam Leive & Daniel McFadden, 2017. "A Cautionary Tale in Comparative Effectiveness Research: Pitfalls and Perils of Observational Data Analysis," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 55-80, National Bureau of Economic Research, Inc.
    14. Adam Leive & Thomas Stratmann, 2015. "Do national cancer screening guidelines reduce mortality?," Journal of Population Economics, Springer;European Society for Population Economics, vol. 28(4), pages 1075-1095, October.

    More about this item

    Keywords

    Pharmaceutical R&D; Human experimentation; Institutional Review Board; Informed consent; Intellectual property rights; Medical researcher and research subject; I11;
    All these keywords.

    JEL classification:

    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kap:ejlwec:v:35:y:2013:i:1:p:61-85. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: . General contact details of provider: http://www.springer.com .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.